# Wuhan Humanwell Likang Pharmaceutical Co.,Ltd. – FDA Inspection, Mar 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/wuhan-humanwell-likang-pharmaceutical-coltd/9d60d783-962e-4500-a7e7-acd04cf1f316
Source feed: FDA_Inspections

> FDA inspection 1266967 of Wuhan Humanwell Likang Pharmaceutical Co.,Ltd., March 07, 2025. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266967
- Company Name: Wuhan Humanwell Likang Pharmaceutical Co.,Ltd.
- Inspection Date: 2025-03-07
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1113116 - 2019-08-23](https://www.keypedia.com/records/fda_inspections/wuhan-humanwell-likang-pharmaceutical-coltd/1a7383f9-89ab-4d24-bdaf-dba775cc01de)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)

Company: https://www.keypedia.com/companies/wuhan-humanwell-likang-pharmaceutical-coltd/e53f31a0-59bc-4627-a164-a7077bf7da5a

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8